Multiple biopharma companies announced leadership changes in legal and compliance functions, reflecting continued emphasis on governance as commercial footprints expand. Aquestive Therapeutics appointed Thomas A. Zalewski as chief legal and compliance officer, with Lori Braender stepping down from those roles while remaining corporate secretary. Arcutis Biotherapeutics promoted Mas Matsuda to executive vice president and chief legal officer, keeping him in charge of legal, compliance, and governance strategy. Coverage also included an appointment by Greenberg Traurig to expand its Health Care and FDA practice. For industry observers, the pattern points to scaling compliance capacity alongside product approvals and broader regulatory exposure, particularly for companies managing complex payer, CDx/biomarker, and patient-support obligations.